6-31946269-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBP7
The NM_001710.6(CFB):c.48G>A(p.Leu16Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000151 in 1,460,780 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000015 ( 0 hom. )
Consequence
CFB
NM_001710.6 synonymous
NM_001710.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.28
Genes affected
CFB (HGNC:1037): (complement factor B) This gene encodes complement factor B, a component of the alternative pathway of complement activation. Factor B circulates in the blood as a single chain polypeptide. Upon activation of the alternative pathway, it is cleaved by complement factor D yielding the noncatalytic chain Ba and the catalytic subunit Bb. The active subunit Bb is a serine protease which associates with C3b to form the alternative pathway C3 convertase. Bb is involved in the proliferation of preactivated B lymphocytes, while Ba inhibits their proliferation. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. This cluster includes several genes involved in regulation of the immune reaction. Polymorphisms in this gene are associated with a reduced risk of age-related macular degeneration. The polyadenylation site of this gene is 421 bp from the 5' end of the gene for complement component 2. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 6-31946269-G-A is Benign according to our data. Variant chr6-31946269-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2722524.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.28 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFB | NM_001710.6 | c.48G>A | p.Leu16Leu | synonymous_variant | Exon 1 of 18 | ENST00000425368.7 | NP_001701.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFB | ENST00000425368.7 | c.48G>A | p.Leu16Leu | synonymous_variant | Exon 1 of 18 | 1 | NM_001710.6 | ENSP00000416561.2 | ||
ENSG00000244255 | ENST00000456570.5 | c.1571-104G>A | intron_variant | Intron 13 of 29 | 2 | ENSP00000410815.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD2 exomes AF: 0.00000406 AC: 1AN: 246290 AF XY: 0.00000745 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
246290
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1460780Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 726702 show subpopulations
GnomAD4 exome
AF:
AC:
22
AN:
1460780
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
726702
Gnomad4 AFR exome
AF:
AC:
0
AN:
33478
Gnomad4 AMR exome
AF:
AC:
2
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26136
Gnomad4 EAS exome
AF:
AC:
0
AN:
39700
Gnomad4 SAS exome
AF:
AC:
0
AN:
86258
Gnomad4 FIN exome
AF:
AC:
0
AN:
52320
Gnomad4 NFE exome
AF:
AC:
19
AN:
1112010
Gnomad4 Remaining exome
AF:
AC:
1
AN:
60386
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Aug 01, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at